Abstract

The public is faced with a lot of contradictory information and dilemmas about the status of the Institute of Immunology in the government finance system. The Institute's financial position is unclear, as are arguments for its privatisation or possible reasons for staying in state ownership. This analysis is aimed at briefly clarifying the Institute's financial position and examining the justifiability of its privatisation vs. remaining in the state’s portfolio.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.